Uncommon mutational profiles of metastatic colorectal cancer detected during routine genotyping using next generation sequencing

RAS genotyping is mandatory to predict anti-EGFR monoclonal antibodies (mAbs) therapy resistance and BRAF genotyping is a relevant prognosis marker in patients with metastatic colorectal cancer. Although the role of hotspot mutations is well defined, the impact of uncommon mutations is still unknown...

Descripción completa

Detalles Bibliográficos
Autores principales: Franczak, Claire, Kandathil, Shaun M., Gilson, Pauline, Husson, Marie, Rouyer, Marie, Demange, Jessica, Leroux, Agnès, Merlin, Jean-Louis, Harlé, Alexandre
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6506598/
https://www.ncbi.nlm.nih.gov/pubmed/31068650
http://dx.doi.org/10.1038/s41598-019-43646-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6506598/
https://www.ncbi.nlm.nih.gov/pubmed/31068650
http://dx.doi.org/10.1038/s41598-019-43646-0

Ejemplares similares